Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Firms Told To Get Ready Now For New EU HTA Regulation

Executive Summary

Comparator selection and joint scientific consultation slots are among top concerns for companies operating in the EU as EUnetHTA 21 consortium preparations for new HTA regulations get going.

You may also be interested in...



European HTA Legislation Clears Final Hurdle

Risk of unpredictable system still real depending on how EU member states approach joint clinical assessments, warns industry.

New EU HTA Consortium Prepares To Launch

Two new groups have been formed in preparation for the application of the EU regulation on health technology assessment cooperation.

Added Benefit For Orphans Is ‘Fictitious’ Says German HTA Body

Industry has warned that reforming the system for evaluating orphan drugs could have serious consequences for patient access.

Topics

UsernamePublicRestriction

Register

PS145434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel